Literature DB >> 16917431

Critical care considerations of hematopoietic stem cell transplantation.

Ayman O Soubani1.   

Abstract

OBJECTIVE: To review the available clinical data on the critical care complications of hematopoietic stem cell transplantation (HSCT). DATA SOURCE: The MEDLINE database and references from the identified articles related to the critical care in HSCT.
CONCLUSION: HSCT is an important treatment for a variety of malignant and nonmalignant conditions. The procedure is, however, limited by significant complications that may involve every organ of the body. Up to 40% of HSCT recipients are admitted to the intensive care unit as a result of severe complications related to the transplantation. The outcome of those critically ill patients has been traditionally poor. However, recent advances in the transplantation procedure, diagnostic studies, antimicrobial prophylaxis and therapy, and intensive care unit care have improved the outcome of these patients. The increasing number of HSCTs performed annually, the unique complications that develop in these patients, and the improvement in the intensive care unit outcome make knowledge about the critical care aspect of HSCT an essential part of the current practice of critical care medicine.

Entities:  

Mesh:

Year:  2006        PMID: 16917431     DOI: 10.1097/01.CCM.0000231886.80470.B6

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  8 in total

1.  A reappraisal of ICU and long-term outcome of allogeneic hematopoietic stem cell transplantation patients and reassessment of prognosis factors: results of a 5-year cohort study (2009-2013).

Authors:  L Platon; L Amigues; P Ceballos; N Fegueux; D Daubin; N Besnard; R Larcher; L Landreau; C Agostini; S Machado; O Jonquet; K Klouche
Journal:  Bone Marrow Transplant       Date:  2015-11-16       Impact factor: 5.483

2.  Open the doors of the ICU to patients with malignancies and neurological complications.

Authors:  Michael Piagnerelli; Benjamin Legros
Journal:  Intensive Care Med       Date:  2009-11-12       Impact factor: 17.440

3.  Patient and family caregiver dyadic adherence to the allogeneic hematopoietic cell transplantation medical regimen.

Authors:  Donna M Posluszny; Dana H Bovbjerg; Mounzer E Agha; Jing-Zhou Hou; Anastasios Raptis; Michael M Boyiadzis; Jacqueline Dunbar-Jacob; Richard Schulz; Mary Amanda Dew
Journal:  Psychooncology       Date:  2017-03-08       Impact factor: 3.894

Review 4.  Intensive care outcomes in adult hematopoietic stem cell transplantation patients.

Authors:  Ulas D Bayraktar; Joseph L Nates
Journal:  World J Clin Oncol       Date:  2016-02-10

5.  Outcome and prognostic indicators of patients with hematopoietic stem cell transplants admitted to the intensive care unit.

Authors:  Thanh N Huynh; S Sam Weigt; John A Belperio; Mary Territo; Michael P Keane
Journal:  J Transplant       Date:  2009-09-15

Review 6.  Mesenchymal stem cell: present challenges and prospective cellular cardiomyoplasty approaches for myocardial regeneration.

Authors:  Debayon Paul; Samson Mathews Samuel; Nilanjana Maulik
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

7.  Invasive fungal infection among hematopoietic stem cell transplantation patients with mechanical ventilation in the intensive care unit.

Authors:  Chen-Yiu Hung; Kuo-Chin Kao; Po-Nan Wang; Han-Chung Hu; Meng-Jer Hsieh; Jui-Ying Fu; Chih-Hao Chang; Li-Fu Li; Chung-Chi Huang; Ying-Huang Tsai; Cheng-Ta Yang
Journal:  BMC Infect Dis       Date:  2012-02-18       Impact factor: 3.090

8.  It Takes a Team to Make It Through: The Role of Social Support for Survival and Self-Care After Allogeneic Hematopoietic Stem Cell Transplant.

Authors:  Yaena Song; Stephanie Chen; Julia Roseman; Eileen Scigliano; William H Redd; Gertraud Stadler
Journal:  Front Psychol       Date:  2021-03-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.